GIRARDIS, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 40.204
NA - Nord America 37.271
AS - Asia 19.337
SA - Sud America 2.975
AF - Africa 439
OC - Oceania 98
Continente sconosciuto - Info sul continente non disponibili 34
Totale 100.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.476
IT - Italia 23.395
GB - Regno Unito 6.243
SG - Singapore 5.514
CN - Cina 5.015
SE - Svezia 3.129
HK - Hong Kong 2.527
BR - Brasile 2.204
VN - Vietnam 2.147
DE - Germania 1.566
FR - Francia 1.338
BD - Bangladesh 1.013
FI - Finlandia 1.013
RU - Federazione Russa 780
UA - Ucraina 774
KR - Corea 603
TR - Turchia 507
CA - Canada 455
IN - India 430
ID - Indonesia 423
NL - Olanda 411
BG - Bulgaria 334
AR - Argentina 277
MX - Messico 195
ES - Italia 159
IQ - Iraq 155
JP - Giappone 153
PL - Polonia 149
EC - Ecuador 123
IE - Irlanda 120
CO - Colombia 110
PK - Pakistan 107
CH - Svizzera 100
LT - Lituania 97
ZA - Sudafrica 93
AT - Austria 91
AU - Australia 86
IR - Iran 83
AE - Emirati Arabi Uniti 76
CL - Cile 67
BE - Belgio 61
VE - Venezuela 61
SA - Arabia Saudita 60
MY - Malesia 59
CZ - Repubblica Ceca 54
RO - Romania 54
MA - Marocco 52
EG - Egitto 51
PH - Filippine 51
DK - Danimarca 49
UZ - Uzbekistan 49
PY - Paraguay 45
TN - Tunisia 43
NP - Nepal 40
PE - Perù 39
KE - Kenya 37
SI - Slovenia 36
TH - Thailandia 36
JO - Giordania 33
AZ - Azerbaigian 32
HU - Ungheria 32
CR - Costa Rica 29
ET - Etiopia 29
KZ - Kazakistan 29
NO - Norvegia 29
EU - Europa 28
GR - Grecia 27
LB - Libano 27
BO - Bolivia 26
DO - Repubblica Dominicana 23
DZ - Algeria 23
PT - Portogallo 22
UY - Uruguay 20
RS - Serbia 19
HN - Honduras 18
IL - Israele 18
AL - Albania 17
SN - Senegal 17
JM - Giamaica 16
OM - Oman 16
PS - Palestinian Territory 16
HR - Croazia 15
SY - Repubblica araba siriana 15
TW - Taiwan 15
MD - Moldavia 14
PA - Panama 13
BY - Bielorussia 12
EE - Estonia 12
NG - Nigeria 12
GA - Gabon 11
GE - Georgia 11
SM - San Marino 11
NI - Nicaragua 10
NZ - Nuova Zelanda 10
QA - Qatar 10
BH - Bahrain 9
TT - Trinidad e Tobago 9
AO - Angola 8
LK - Sri Lanka 8
LV - Lettonia 8
Totale 100.174
Salva come PNG Salva come JPEG
Città #
Southend 4.526
Santa Clara 3.809
Ashburn 3.711
Singapore 3.511
Fairfield 3.285
Hong Kong 2.472
Woodbridge 2.065
Chandler 1.944
Stockholm 1.806
Houston 1.642
Jacksonville 1.430
Hefei 1.418
Milan 1.365
San Jose 1.272
Seattle 1.226
Rome 1.060
Wilmington 1.051
Cambridge 1.047
Dearborn 1.034
London 1.004
Nyköping 956
Ann Arbor 942
Beijing 936
Council Bluffs 722
Helsinki 689
Ho Chi Minh City 679
Bologna 664
Los Angeles 640
Modena 615
Seoul 560
Hanoi 518
New York 486
Chicago 484
The Dalles 463
San Diego 420
Princeton 380
Florence 335
Lauterbourg 321
Sofia 316
Jakarta 315
Torino 310
Dallas 305
Turin 301
Buffalo 273
Moscow 267
Munich 256
Eugene 249
Naples 221
Shanghai 219
Catania 217
São Paulo 197
Izmir 196
Palermo 185
Redwood City 184
Boardman 176
Salt Lake City 165
Verona 160
Padova 156
Toronto 145
Orem 139
Genova 134
Frankfurt am Main 130
Castelnuovo Rangone 125
Parma 123
Pisa 119
Bari 114
Genoa 114
Dublin 108
Napoli 107
Venezia 107
Tokyo 106
Reggio Nell'emilia 100
Des Moines 96
Nuremberg 96
Da Nang 95
Haiphong 95
Phoenix 89
Tampa 88
Warsaw 87
Guangzhou 85
Elk Grove Village 84
Trento 79
Rio de Janeiro 75
Trieste 74
Mumbai 72
Bremen 70
Brescia 70
Miano 69
Montreal 69
Amsterdam 66
Mexico City 63
Chennai 62
Monza 62
Bolzano 61
Norwalk 61
Reggio Emilia 61
Paris 60
Redondo Beach 58
Turku 57
Columbus 55
Totale 59.886
Salva come PNG Salva come JPEG
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.265
EPIDEMIA DA INFEZIONE DI BURKHOLDERIA CEPACIA IN TERAPIA INTENSIVA: SORVEGLIANZA E CONTROLLO 4.225
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 1.932
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit 884
Acute renal failure and renal replacement therapy in the postoperative period of orthotopic liver transplant patients versus nonelective abdominal surgery patients 876
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 804
Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial 763
Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis 729
Intravenous immunoglobulin in septic shock: review of the mechanisms of action and meta-analysis of the clinical effectiveness 722
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 515
Oxygen in the critically ill: friend or foe? 473
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 471
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 455
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 437
Levosimendan in cardiac failure after subarachnoid hemorrhage. 432
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 429
Current gaps in sepsis immunology: new opportunities for translational research 422
Metabolic reprograming shapes neutrophil functions in severe COVID-19 411
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 406
A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report 395
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 393
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 377
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 373
Pain management after small bowel/multivisceral transplantation 372
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 369
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 367
Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia 362
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 360
A new device for ultrasound-guided peripheral venous access 353
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 351
A one-year prospective study of refractory status epilepticus in Modena, Italy 349
Endotoxin activity levels as a prediction tool for risk of deterioration in patients with sepsis not admitted to the intensive care unit: a pilot observational study 348
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 346
Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. 338
JLB: a flexible and effective device in critical patients. Review of clinical cases 337
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 337
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 335
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial 331
Wernicke's encephalopathy in a malnourished surgical patient: a difficult diagnosis 331
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 331
The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) 330
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 329
Effectiveness of sepsis bundle application in cirrhotic patients with septic shock: A single-center experience 329
A new technique for percutaneous dilatational tracheostomy (G-Trach): Preliminary experience in pigs 327
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 326
Hypokalemia in Patients with COVID-19 324
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial 323
Purpura Fulminans and Septic Shock due to Capnocytophaga Canimorsus after Dog Bite: A Case Report and Review of the Literature 322
Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: State-of-the-art and expert consensus 321
A Janus role for MerTK in the outcome of septic shock 319
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 316
The prognostic importance of chronic end-stage diseases in geriatric patients admitted to 163 Italian ICUs 316
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 314
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial 312
Comment on [A modified goal-directed protocol improves clinical outcome in intensive care unit patients with septic shock patients: a randomized controlled trial.] 309
Impact of Pre-Analytical Time on the Recovery of Pathogens from Blood Cultures: Results from a Large Retrospective Survey 309
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. 307
Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study 306
Anestesia e disordini vasculo-polmonari nel paziente epatopatico: iter diagnostico e ruolo dello screening precoce 304
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 304
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 303
Peritoneal dialysis in the time of coronavirus disease 2019 303
Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies 300
Management of Sepsis in the First 24 Hours: Bundles of Care and Individualized Approach 299
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 291
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 286
Characteristics and outcome predictors of patients involved in an outbreak of Burkholderia cepacia complex 285
Muscle perfusion and oxygen consumption by near-infrared spectroscopy in septic-shock and non-septic-shock patients 284
Incidence and clinical outcomes of ventilator-associated pneumonia in liver transplant and non-liver transplant surgical patients. 284
Case report of a patient who survived after cardiac arrest and cardiogenic shock by anaphylactic reaction to gadolinium during magnetic resonance imaging 282
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 282
Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock 280
World Society of Emergency Surgery (WSES) guidelines for management of skin and soft tissue infections 280
CYTOREDUCTIVE SURGERY AND HIPEC IN A 14 YEARS OLD PATIENT WITH PERITONEAL RECURRENCE OF ADENOCARCINOMA OF THE RIGHT COLON 280
The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome 279
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 278
PSP/reg: a new stone in sepsis biomarkers? 276
Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments 276
Use of recombinant factor VIIa in thrombocytopenic patient with spontaneous intracerebral haemorrhage. 274
Intra-abdominal hypertension in nonelective surgery: A preliminary report 273
Bronchoalveolar lavage (BAL) and supplementation with exogenous surfactant in adults with acute respiratory distress syndrome (ARDS) 273
Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria 271
Erratum to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC‑GLOSSARI): a multicenter, multinational, 14-day inception cohort study (Intensive Care Medicine, (2016), 42, 5, (953), 10.1007/s00134-016-4317-4) 270
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 270
Delayed upper airway obstruction following a retropharyngeal haematoma after minor head trauma. 266
Never Give Up: lesson learned from a severe COVID-19 patient. 265
Whole-genome sequencing reveals host factors underlying critical COVID-19 264
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 261
Immune System Dysfunction and Multidrug-resistant Bacteria in Critically Ill Patients: Inflammasones and Future Perspectives 260
The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections 259
Trends in ventilator-associated pneumonia: Impact of a ventilator care bundle in an Italian tertiary care hospital intensive care unit 258
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 256
Use of activated protein C in liver transplantation patients with septic shock. 255
Tracheostomy in the COVID-19 pandemic 254
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 254
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 253
The effect of laparoscopic cholecystectomy on cardiovascular function and pulmonary gas exchange. 252
Dexmedetomidine for agitated delirium in intensive care unit intubated patients 252
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 252
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway 250
Totale 55.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 345.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 345.677
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021626 0 0 0 0 0 0 0 0 0 0 0 626
2021/20227.795 596 778 686 462 313 404 512 486 856 550 1.058 1.094
2022/20238.797 953 864 675 722 869 992 390 828 1.016 339 585 564
2023/20246.790 461 553 541 724 1.052 526 567 785 222 249 361 749
2024/202515.022 569 379 306 1.147 2.709 2.256 902 886 1.836 960 1.298 1.774
2025/202628.382 1.679 1.085 2.498 3.044 3.380 1.486 3.281 1.487 4.162 2.545 2.170 1.565
Totale 101.146